Alvogen, a Pine Brook-based pharmaceutical company, announced Tuesday that it has agreed to acquire Omega Bittner, a Russia-based pharmaceutical firm owned by Perrigo Company plc.
“This acquisition supports our strategy to gain more exposure to Russia’s high growth market. It will create greater scale and diversity across our portfolio and sales channels, while increasing market share in women’s health care and cough and cold,” Hacho Hatchikian, executive vice president of Alovgen CEE, said.
“I would like to welcome Omega Bittner's talented and dedicated workforce to the Alvogen family and look forward to their contributions, as we strive to provide patients in the region with highest quality products and services.”
The transaction is expected to close in the third quarter of 2017.